The Search for New Drugs: Part II

The transcript discusses Pfizer's approach to R&D spending, focusing on improving productivity by selecting specific therapeutic areas and restructuring research and development processes. It highlights the importance of balancing internal and external investments, reducing failure rates, and utilizing AI and data in clinical trials. The discussion also touches on the challenges of drug development, particularly in areas like Alzheimer's, and the need for regulatory and patent system adaptations.

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF